Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tm Bioscience licenses patents for CF (cystic fibrosis) gene test:

This article was originally published in Clinica

Executive Summary

Tm Bioscience has acquired a non-exclusive licence for cystic fibrosis (CF) gene mutation patents for use in its Tag-It mutation detection kit. The Tag-It CF test, the firm's flagship product, is currently being assessed by potential customers and is expected to reach the market in the third quarter of 2003, says the Toronto, Ontario company. The CF patents were licensed from The Hospital for Sick Children, also in Toronto, Ontario, and the University of Michigan, in Ann Arbor, Michigan. Other tests in the firm's pipeline include those for genetic mutations related to haematology, toxicology and other debilitating genetic disorders.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062753

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel